Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

telegraph.co.uk

1 of 0

Resource Description:

GlaxoSmithKline is to triple production of its swine flu treatment Relenza and plans to have anti swine flu vaccine in distribution by September, the company revealed as it presented second quarter results on Wednesday.

« Back to the Maker of Swine Flu Vaccine WisdomCard

Related Health Centers:

Advertisement